Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide (Genvoya)

Status:
Red
Decision Date:
April 2023
 

Comments

RED: Treatment of human immunodeficiency virus-1 infection without any known mutations associated with resistance to the integrase inhibitor class.

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app